Canagliflozin inhibits interleukin-1β-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms.

about

Canagliflozin inhibits interleukin-1β-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms.

Item

http://www.wikidata.org/entity/Q54119005

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Canagliflozin inhibits interle ...... t and -independent mechanisms.

@en

Canagliflozin inhibits interle ...... t and -independent mechanisms.

@nl

type

Item

label

Canagliflozin inhibits interle ...... t and -independent mechanisms.

@en

Canagliflozin inhibits interle ...... t and -independent mechanisms.

@nl

prefLabel

Canagliflozin inhibits interle ...... t and -independent mechanisms.

@en

Canagliflozin inhibits interle ...... t and -independent mechanisms.

@nl

P1476

Canagliflozin inhibits interle ...... nt and -independent mechanisms

@en

P2093

Anastasiya Strembitska

http://www.w3.org/2001/XMLSchema#string

Daria Boyd

http://www.w3.org/2001/XMLSchema#string

Omar J Katwan

http://www.w3.org/2001/XMLSchema#string

Sarah J Mancini

http://www.w3.org/2001/XMLSchema#string

Tarek A Almabrouk

http://www.w3.org/2001/XMLSchema#string

Timothy M Palmer

http://www.w3.org/2001/XMLSchema#string

P2860

The selectivity of protein kinase inhibitors: a further update

SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?

The TLR and IL-1 signalling network at a glance

Nitric oxide-induced activation of the AMP-activated protein kinase α2 subunit attenuates IκB kinase activity and inflammatory responses in endothelial cells

Structural basis of AMPK regulation by small molecule activators

The alpha1 and alpha2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro

Effect of canagliflozin on renal threshold for glucose, glycemia, and body weight in normal and diabetic animal models

5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?

Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase.

Anti-inflammatory therapies for cardiovascular disease

P304

5276

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-018-23420-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ian P Salt

Simon Kennedy

P577

2018-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29588466

http://www.w3.org/2001/XMLSchema#string

P932

5869674

http://www.w3.org/2001/XMLSchema#string